CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishTriple negative breast cancer (TNBC) stands out for a remarkable morphological and biological heterogeneity associated with a high propensity for systemic metastases and poor survival in comparison with the different subtype of breast cancer. The efforts to adopt specific target therapies are complicated by the difficulty to identify representative and reproducible markers. Recently, there is increasing evidence of the role of tumorinfiltrating lymphocytes (TILs) in this subtype of breast cancer in terms ofimproving disease-free (DFS) and overall survival (OS) rates.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | Tumor infiltrating lymphocyte (TIL) and CD8+ cells in TNBC: new prognostic markers |
| Autori: | |
| Data di pubblicazione: | 2016 |
| Rivista: | |
| Abstract: | Triple negative breast cancer (TNBC) stands out for a remarkable morphological and biological heterogeneity associated with a high propensity for systemic metastases and poor survival in comparison with the different subtype of breast cancer. The efforts to adopt specific target therapies are complicated by the difficulty to identify representative and reproducible markers. Recently, there is increasing evidence of the role of tumorinfiltrating lymphocytes (TILs) in this subtype of breast cancer in terms ofimproving disease-free (DFS) and overall survival (OS) rates. |
| Handle: | http://hdl.handle.net/11392/2366057 |
| Appare nelle tipologie: | 03.5 Abstract su rivista |
File in questo prodotto:
Copyright © 2020